Elyse Watkins, PhD, PA-C
Purpose: The purpose of this article is to review the available data on risk of HCC in NAFLD and NASH.
Method: A PubMed literature search was conducted with search terms HCC, NASH, NAFLD. and fatty liver. Eight articles were examined as the basis for the review article.
Results: While there are not current guidelines for screening for HCC in the non-cirrhotic NAFLD/NASH population, the data reviewed clearly shows a risk of HCC in this population.
Conclusion: NASH and NAFLD, regardless of the degree of liver fibrosis, present a risk for development of HCC. While current recommendations exist for screening cirrhotic patients for HCC, no guidance exists for screening in the non-cirrhotic population. Further data on the long term outcomes of screening in non-cirrhotic patients, as well as cost analysis of screening, is warranted in order to better inform future guidance committees.
Keywords: NASH, NAFLD, fatty liver, non-cirrhotic, HCC, hepatocellular carcinoma
Lee SM. The Need for HCC Screening in NASH. University of Lynchburg DMSc Doctoral Project Assignment Repository. 2019; 1(4).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.